Thrombopoietin responsiveness reflects the number of doublings undergone by megakaryocyte progenitors

Blood

Volumn 104, Issue 8, 2004, Pages 2291-2298

  Paulus, Jean Michel ^a   Debili, Najet ^b   Larbret, Frédéric ^b   Levin, Jack ^b   Vainchenker, William ^b  

^a CHU SART TILMAN   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; FIBRINOGEN RECEPTOR; MEMBRANE ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN MPL; THROMBOPOIETIN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CLONE; COLONY FORMING UNIT; COLONY FORMING UNIT GM; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; MEGAKARYOCYTE; POLYPLOIDY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STEM CELL;

EID: 4944247167     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-05-1745     Document Type: Article

References (50)

1. Paulus JM, Prenant M, Deschamps JF, Henry-Amar M. Polyploid megakaryocytes develop randomly from a multicompartmental system of committed progenitors. Proc Natl Acad Sci USA. 1982;79:4410-4414.
2. Paulus JM, Levin J, Debili N, Albert A, Vainchenker W. Genesis of clone size heterogeneity in megakaryocytic and other hemopoietic colonies. The stochastic model revisited. Exp Hematol. 2001:29:1256-1269.
3. Orkin SH. Transcription factors regulating early hematopoietic development and lineage commitment. In: Monroe JG, Rothenberg EV, eds. Molecular biology of B-cell and T-cell development. Totowa, NJ: Humana Press; 1999:41-54.
4. WAF1/Cipl by STATS. Mol Cell Biol. 1997;17:2933-2943.
5. Nagata Y, Muro Y, Toobkoro K. Thrombopoietin-induced polyploidization of bone marrow megakaryocytes is due to a unique regulatory mechanism in late mitosis. J Cell Biol. 1997:139:449-457.
6. Vitrat M, Cohen-Solal K, Pique C, et al. Endomitosis of human megakaryocytes are due to abortive mitosis. Blood. 1998:91:3711-3723.
7. Huang C, Ferrell J Jr. Ultrasensitivity in the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA. 1996:93:10078-10083.
8. Ferrell JE, Machleder EM. The biochemical basis of an all-or-none cell fate switch in Xenopus oocytes. Science. 1998;280:895-898.
9. Matsumura I, Nakajima K, Wakao H, et al. Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line. Mol Cell Biol. 1998:18:4282-4290.
10. Rojnuckarin P, Drachmen JG, Kaushansky K. Thrombopoietin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocytes: role in endomitosis. Blood. 1999;94:1273-1282.
11. Fichelson S, Freyssinier JM, Picard F, et al. Megakaryocyte growth and development factor-induced proliferation and differentiation are regulated by the mitogen-activated protein kinase pathway in primitive cord blood hematopoietic progenitors. Blood. 1999;94:1601-1613.
12. Levin J, Levin FC, Penington DG, Metcalf D. Measurement of ploidy distribution in megakaryocyte colonies obtained from culture: with studies of the effects of thrombocytopenia. Blood. 1981;57:287-297.
13. Metcalf D. Clonal analysis of proliferation and differentiation of paired daughter cells: action of granulocyte-macrophage colony-stimulating factor on granulocyte-macrophage precursors. Proc Natl Acad Sci U S A. 1980:77:5327-5330.
14. Bruno E, Huffman R. Human megakaryocyte progenitor cells. Semin Hematol. 1998;35:183-191.
15. Francis GE, Berney JJ, Bodger MP, et al. Clone size potential and sensitivity to colony-stimulating activity: differentiation-linked properties of granulocyte-macrophage progenitor cells. Stem Cells. 1981:1:124-139.
16. Eaves CJ, Eaves AC. Erythropoietin (Ep) dose-response curves for three classes of erythroid progenitors in normal human marrow and in patients with polycythemia vera. Blood. 1978;52:1196-1210.
17. Long MW, Heffner CH, Gragowski LL. In vitro differences in responsiveness of early (BFU-Mk) and late (CFU-Mk) murine megakaryocyte progenitor cells. Prog Clin Biol Res. 1986;215:179-186.
18. Mintem J, Williams N, Jackson H. The relative population sizes of megakaryocytic cells in mouse bone marrow as determined by mpl ligand responsiveness. Exp Hematol. 1997:25:1233-1239.
19. Leary AG, Strauss LC, Civin CI, Ogawa M. Disparate differentiation in hemopoietic colonies derived from human paired progenitors. Blood. 1985:66:327-332.
20. Huang S, Law P, Francis K, Palsson BO, Ho AD. Symmetry of initial cell divisions among primitive hematopoietic progenitor is independent of ontogenic age and regulatory molecules. Blood. 1999;94:2595-2604.
21. Punzel M, Liu D, Zhang T, et al. The symmetry of initial divisions of human hematopoietic progenitors is altered only by the cellular microenvironment. Exp Hematol. 2003:31:339-347.
22. Takano H, Ema H, Sudo K, Nakauchi H. Asymmetric division and lineage commitment at the level of hematopoietic stem cells: inference from differentiation in daughter cell and granddaughter cell pairs. J Exp Med. 2004:199:295-302.
23. Nutt SL, Heavey B, Rolink AG, Busslinger M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature. 1999;401:556-562.
24. Kondo M, Scherer DC, Miyamoto T, et al. Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature. 2000:407:383-386.
25. Stellacci E, Testa U, Petrucci E, et al. Interferon regulatory factor-2 drives megakaryocytic differentiation. Biochem J. 2004:377:367-378.
26. Debili N, Coulombel L, Croisille L, et al. Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow. Blood. 1996;88:1284-1296.
27. Debili N, Wendling F, Katz A, et al. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood. 1995;86:2516-2525.
28. Debili N, Robin C, Schiavon V, et al. Different expression of CD41 on human lymphoid and myeloid progenitors from adults and neonates. Blood. 2001:97:2023-2030.
29. Kato T, Horie K, Hagiwara T, et al. GpIIb/IIIa+ subpopulation of rat megakaryocyte progenitor cells exhibits high responsiveness to human thrombopoietin. Exp Hematol. 1996;24:1209-1214.
30. Debili N, Wendling F, Cosman D, et al. The MpI receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood. 1995:85:391-401.
31. Debili N, Issaad C, Massé JM, et al. Expression of CD34 and platelet glycoproteins during human megakaryocytic differentiation. Blood. 1992;80:3022-3035.
32. den Dekker E, van Abel M, van der Vuurst H, van Eys GJ, Akkerman JW, Heemskerk JW. Cell-to-cell variability in the differentiation program of human megakaryocytes. Biochim Biophys Acta. 2003:1643:85-94.
33. Deveaux S, Filipe A, Lemarchandel V, et al. Analysis of the thrombopoietin receptor (MPL) promoter implicates GATA and Ets proteins in the coregulation of megakaryocyte-specific genes. Blood. 1996:87:4678-4685.
34. Lemarchandel V, Ghysdael J, Mignotte V, Rahuel C, Romeo PH. GATA and Ets cis-acting sequences mediate megakaryocyte-specific expression. Mol Cell Biol. 1993:13:668-676.
35. Hashimoto Y, Ware J. Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Ib alpha gene. J Biol Chem. 1995:270:24532-24539.
36. Aitchison J, Brown J. The lognormal distribution with special reference to its use in economics. Cambridge, United Kingdom: Cambridge University Press: 1957.
37. Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell. 1995:80:179-185.
38. Dikic I, Schlessinger J, Lax I. PC12 cells overexpressing the insulin receptor undergo insulin-dependent neuronal differentiation. Curr Biol. 1994;4:702-708.
39. Gao FB, Apperly J, Raff M. Cell-intrinsic timers and thyroid hormone regulate the probability of cell-cycle withdrawal and differentiation of oligodendrocyte precursor cells. Dev Biol. 1998:197:54-66.
40. Metcalf D, MacDonald HR. Heterogeneity of in vitro colony- and cluster-forming cells in the mouse marrow: segregation by velocity sedimentation. J Cell Physiol. 1975:85:643-654.
41. Labbaye C, Quarante MT, Pagliuca A, et al. PLZF induces megakaryocytic development, activates Tpo receptor expression and interacts with GATA1 protein. Oncogene. 2002:21:6669-6679.
42. Correa PN, Axelrad AA. Production of erythropoietic bursts by progenitor cells from adult human peripheral blood in an improved serum-free medium: role of insulinlike growth factor 1. Blood. 1991:78:2823-2833.
43. Koury MJ. Programmed cell death (apoptosis) in hematopoiesis. Exp Hematol. 1992;20:391-394.
44. Kelley LL, Koury MJ, Bondurant MC, et al. Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: a mechanism for controlled rates of erythrocyte production. Blood. 1993:82:2340-2352.
45. Majka M, Janowska-Wieczorek A, Ratajczak J, et al. Stromal-derived factor 1 and thrombopoietin regulate distinct aspects of human megakaryopoiesis. Blood. 2000;96:4142-4151.
46. Pestina TI, Cleveland JL, Yang CY, Zambetti GP, Jackson CW. MpI ligand prevents lethal myelosuppression by inhibiting p53-dependent apoptosis. Blood. 2001;98:2084-2090.
47. Millot GA, Vainchenker W, Dumenil D, Svinarchuk F. Distinct effects of thrombopoietin depending on a threshold level of activated MpI in BaF-3 cells. J Cell Sci. 2002:115:2329-2337.
48. Kirito K, Watanabe T, Sawada K, et al. Thrombopoietin regulates Bcl-xL gene expression through Stats and phosphatidylinositol 3-kinase activation pathways. J Biol Chem. 2002;277:8329-8337.
49. Tanaka R, Katayama N, Ohishi K, et al. Accelerated cell-cycling of hematopoietic progenitor cells by growth factors. Blood. 1995:86:73-79.
50. Muta K, Krantz SB, Bondurant MC, Dai CH. Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation. Blood. 1995:86:572-580.